Contact Us

The choice depends on whether you are studying TRPV6's role in calcium entry, intestinal calcium absorption modeling, or its overexpression effects in cancer. The Knockout line is the standard tool for asking whether TRPV6 is required for store-independent calcium entry in the cellular context being studied. Overexpression is useful for studying cancer-associated TRPV6 upregulation, which has been reported in prostate, breast, and other cancers. For TRPV6 research, the EDITGENE Knockout line in HEK293 is the standard mechanistic platform — TRPV6 has been extensively characterized in HEK293 heterologous expression systems, and the knockout provides a clean background for distinguishing TRPV6-specific calcium entry from TRPV5 and other channel activities. Rescue with wild-type, pore-dead (e.g., D541A), or cancer-associated TRPV6 variants is highly informative for both mechanistic and disease-modeling studies.

Yes. TRPV6 rescue experiments have a well-established framework given extensive prior HEK293-based TRPV6 research: • Construct design: use a codon-modified TRPV6 sequence with a small N- or C-terminal tag (FLAG, HA). Both tag positions are tolerated for TRPV6; bulky tags should be avoided as they may interfere with channel assembly. • Pore-dead rescue: the D541A mutation in the selectivity filter abolishes calcium permeation and is the standard specificity control for distinguishing channel function from non-conducting roles. • Calcium-induced inactivation considerations: TRPV6 exhibits calcium-dependent inactivation — rescue assays should standardize extracellular calcium conditions to allow comparison across constructs. • Functional readout: rescue should restore store-independent calcium entry measured by calcium imaging (Fura-2, Fluo-4) or patch-clamp electrophysiology. HEK293 transduces efficiently with lentivirus and is the standard heterologous expression system for TRP channel research, supporting both polyclonal and clonal rescue line generation.

The choice depends on whether you are studying TRPM4's role in non-selective cation conductance, calcium-activated cation currents, or its emerging functions in glioblastoma biology. The Knockout line is appropriate for asking whether TRPM4 is required for these processes — particularly relevant in U-118MG, where TRPM4 has been reported to contribute to glioblastoma cell proliferation and survival. Overexpression is useful for testing whether elevated TRPM4 is sufficient to drive cation conductance or to alter membrane potential dynamics. For TRPM4 research in glioblastoma contexts, the EDITGENE Knockout line in U-118MG is highly relevant — TRPM4 inhibitors are being investigated as anti-glioblastoma agents, and this knockout provides a critical genetic specificity control for those compounds. Rescue with wild-type or pore-mutant TRPM4 is essential for distinguishing channel function from non-conducting roles.

Yes. TRPM4 rescue experiments require attention to channel assembly and membrane targeting: • Construct design: use a codon-modified TRPM4 sequence with a C-terminal tag (FLAG, HA). TRPM4 is a large six-transmembrane channel — N-terminal tags can interfere with channel topology. • Pore-dead rescue: mutations in the selectivity filter (e.g., E981A in the GE pore loop) abolish cation conductance and serve as the standard specificity control for channel function. • Tetramer assembly considerations: TRPM4 functions as a homotetramer — overexpression should ensure adequate subunit assembly, typically assessed by surface biotinylation or imaging. • Inhibitor specificity controls: rescue with wild-type or specific inhibitor-resistant variants enables testing of 9-phenanthrol and related TRPM4 inhibitors for on-target activity. U-118MG cells are adherent and transduce with lentivirus at standard efficiency; consider clonal selection for quantitative channel function readouts.

The choice depends on whether you are studying TRIM25's role in RIG-I-mediated antiviral signaling or its broader functions in ubiquitin ligase biology. The Knockout line is the standard tool for asking whether TRIM25 is required for K63-linked ubiquitination of RIG-I and downstream type I IFN induction — particularly relevant in A-549, which is widely used in respiratory viral infection studies. Overexpression is useful for testing whether elevated TRIM25 enhances antiviral signaling or for studying TRIM25's RNA-binding functions independent of its E3 ligase activity. For antiviral immunity research, the EDITGENE Knockout line in A-549 is highly informative — A-549 supports replication of many respiratory viruses (influenza, SARS-CoV-2, RSV), enabling direct testing of TRIM25's antiviral functions in a disease-relevant context. Rescue with wild-type, RING-dead, or RNA-binding-deficient TRIM25 is the standard approach for dissecting its dual ligase and RNA-binding activities.

Yes. TRIM25 rescue experiments require attention to its dual E3 ligase and RNA-binding activities: • Construct design: use a codon-modified TRIM25 sequence with a small C-terminal tag (FLAG, HA). TRIM25 contains an N-terminal RING domain that should be preserved with minimal N-terminal modification. • RING-dead rescue: the C20A/H22A double mutation in the RING domain abolishes E3 ligase activity and is the standard control for separating ligase from RNA-binding functions. • RNA-binding-deficient rescue: specific PRY/SPRY domain mutations affect TRIM25's RNA binding without disrupting E3 activity — these constructs are critical for dissecting RNA-binding-specific functions. • Functional readout: rescue should restore RIG-I ubiquitination and IFN induction following viral RNA stimulation in A-549. A-549 transduces efficiently with lentivirus and supports stable rescue line generation; the NSCLC background is particularly suited to studying TRIM25 in respiratory virus infection contexts.

The choice depends on whether you are studying TRIM21's role in intracellular antibody-mediated immunity or its use as the molecular basis for Trim-Away technology. The Knockout line is essential for both — particularly in HeLa, where Trim-Away technology was originally developed and is most extensively validated. Overexpression is useful for boosting Trim-Away efficiency when endogenous TRIM21 is limiting or for studying the consequences of constitutive TRIM21 elevation. For Trim-Away methodology research, the EDITGENE TRIM21 Knockout in HeLa is a critical reference tool — it serves as the negative control demonstrating Trim-Away dependency on TRIM21, and as a clean background for reconstituting Trim-Away with engineered TRIM21 variants. Rescue with wild-type, RING-dead (C16/15A), or Fc-binding-deficient (H433A) TRIM21 dissects the contributions of E3 ligase activity versus antibody binding.

Yes. TRIM21 rescue experiments are well-characterized given TRIM21's importance in Trim-Away technology: • Construct design: use a codon-modified TRIM21 sequence with a small C-terminal tag (FLAG, HA). TRIM21 is small (~475 amino acids); N-terminal tags can interfere with the RING domain. • Trim-Away activity rescue: rescue with wild-type TRIM21 should restore Trim-Away-mediated protein degradation in the knockout background — this is the principal functional readout for HeLa-context rescue. • Structure-function variants: RING-dead (C16A or C15A) and Fc-binding-deficient (H433A) mutants dissect E3 ligase versus antibody-binding functions. • Expression level: TRIM21 expression levels affect Trim-Away efficiency — rescue should approximate or moderately exceed endogenous TRIM21 levels for optimal activity. HeLa transduces efficiently with lentivirus and is the most extensively used cell line for Trim-Away methodology, with established protocols for TRIM21 rescue and engineered variant testing.

The choice depends on whether you are studying TRIM21's biochemistry, its role as an antibody sensor, or its therapeutic implications in adenoviral gene therapy. The Knockout line is the standard tool for mechanistic studies — HEK293 has a long history in TRIM21 biochemistry and structural characterization. Overexpression is useful for testing TRIM21 variants and for in vitro reconstitution studies. For mechanistic TRIM21 research, the EDITGENE Knockout in HEK293 provides a tractable platform with high transfection efficiency for rescue experiments — particularly valuable for structure-function studies and for distinguishing on-target TRIM21 effects from off-target editing artifacts. HEK293 is also relevant for studying TRIM21 interference with adenoviral vector-based gene therapy. Rescue with wild-type and structure-function variants is the standard approach.

Yes. TRIM21 rescue in HEK293 is well-suited for mechanistic and biochemical studies: • Construct design: use a codon-modified TRIM21 sequence with a C-terminal tag (FLAG, HA). HEK293's high transfection efficiency supports rapid screening of TRIM21 variants. • Domain dissection: rescue with PRY-SPRY deletion, B-box mutation, or coiled-coil truncation variants enables dissection of individual functional domains beyond standard RING-dead and Fc-binding mutants. • Autoubiquitination considerations: TRIM21 undergoes RING-dependent autoubiquitination during activation; recent work has shown this is dispensable for substrate degradation — relevant for interpreting rescue with autoubiquitination-deficient variants. • Functional readout: in vitro ubiquitination assays with rescue cell extracts can biochemically confirm TRIM21 enzymatic activity restoration. HEK293 has the highest transfection efficiency among the three TRIM21 product cell lines, making it the preferred choice for systematic structure-function studies and biochemical rescue characterization.

The choice depends on whether you are studying TRIM21's role in intracellular antiviral immunity, particularly in the respiratory pathogen context. The Knockout line is the appropriate tool for asking whether TRIM21 is required for antibody-dependent neutralization of viruses that infect respiratory epithelium. Overexpression is useful for testing whether elevated TRIM21 enhances antibody-mediated neutralization, particularly relevant for emerging respiratory pathogens. For respiratory virus research, the EDITGENE TRIM21 Knockout in A-549 is particularly valuable — A-549 supports replication of many respiratory viruses (adenovirus, influenza, SARS-CoV-2), enabling direct testing of TRIM21's protective antiviral functions in a disease-relevant cellular context. Rescue with wild-type or RING-dead TRIM21 is the standard approach for distinguishing antibody-binding from E3 ligase functions.

Yes. TRIM21 rescue experiments in A-549 are particularly suited to antiviral immunity studies: • Construct design: use a codon-modified TRIM21 sequence with a C-terminal tag (FLAG, HA). Standard TRIM21 expression vectors work well in A-549. • Antiviral function rescue: the principal functional readout for A-549 context is restoration of antibody-mediated intracellular virus neutralization — assays should use antibody-coated virus challenge (adenovirus is the canonical TRIM21 substrate). • Structure-function variants: RING-dead (C16/15A) and Fc-binding-deficient (H433A) TRIM21 dissect E3 ligase versus antibody-binding functions in the respiratory virus infection context. • Functional readout: viral replication assays in rescue cells compared to knockout and parental lines, with and without virus-specific antibody, quantify TRIM21's antiviral contribution. A-549 transduces with lentivirus at standard efficiency for adherent cancer lines and supports stable TRIM21 rescue line generation.

The choice depends on whether you are studying TRIB3's role as a stress-induced pseudokinase, its inhibition of AKT signaling, or its functions in metabolic disease and cancer. The Knockout line is appropriate for asking whether TRIB3 is required for these processes — TRIB3 is a stress-inducible factor that modulates multiple signaling pathways through pseudokinase scaffolding rather than catalytic activity. Overexpression is useful for studying TRIB3 induction effects, particularly relevant given that TRIB3 is normally low in unstressed cells. For TRIB3 research, the EDITGENE Knockout line in HAP1 provides a clean genetic background for dissecting TRIB3-specific signaling functions. Rescue with wild-type or substrate-binding-deficient TRIB3 is the standard approach for assigning observed effects to specific protein-protein interactions, given that TRIB3 lacks catalytic kinase activity.

Yes. TRIB3 rescue experiments require attention to its pseudokinase nature: • Construct design: use a codon-modified TRIB3 sequence with a small C-terminal tag (FLAG, HA). TRIB3 is small (~358 amino acids) and tolerates either N- or C-terminal tagging. • Substrate-binding mutant rescue: since TRIB3 lacks catalytic activity, 'function-dead' controls require disruption of its protein-protein interactions — typically mutations in the pseudokinase domain interfaces with AKT, MAPK, or COP1. • Domain-deletion rescue: separate rescue with the pseudokinase domain alone versus full-length TRIB3 helps map function to specific protein regions. • Functional readout: rescue should restore TRIB3-mediated AKT inhibition (phospho-AKT analysis) or substrate-specific phenotypes. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TRIB1's role as a pseudokinase scaffold or its specific functions in C/EBPα degradation and AML biology. The Knockout line is appropriate for asking whether TRIB1 is required for COP1-mediated C/EBPα ubiquitination — its principal characterized function in myeloid biology. Overexpression is useful for studying TRIB1 in cancer contexts where it is frequently overexpressed. For TRIB1 research, the EDITGENE Knockout line in HAP1 is informative for mechanistic dissection of pseudokinase scaffolding function. Rescue with wild-type or COP1-binding-deficient TRIB1 is the standard approach for distinguishing scaffolding from other functions, given that TRIB1 lacks catalytic activity.